Imaging Study of 3D-CBCT Sialography and MRI Sialography in Non Tumor Salivary Diseases

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 23, 2016

Primary Completion Date

August 18, 2019

Study Completion Date

August 31, 2019

Conditions
Non Tumor Salivary Gland Diseases of the Parotid GlandsNon Tumor Salivary Gland Diseases of the Submandibular Glands
Interventions
OTHER

Three-dimensional sialography CBCT and MRI sialography

"1. MRI sialography: Achieved on a 3 Tesla MRI (INGENA 3T Philips Medical Systems). Patient supine positioned. Sialo-MR sequences (3D T2 DRIVE, TSE, SENSE and SPIR) and conventional sequences (T2 turbo spin echo).~2. 3D CBCT sialography: Achieved same day as the MRI sialography, after acute episode subsided. 0.5ml of high concentration, water-soluble, iodinated contrast product (HEXABRIX 320®, 320g /L, Guerbet, France) is injected in the symptomatic salivary gland and maintained in the gland. Image acquisition performed on a wide-field CBCT device (NewTom VGi, QR, Verona, Italy). Front and profile scout views achieved. mA and exposure time modulated according to scout views. Reconstruction in Maximal Intensity Projection, 3-dimensional and MultiPlanar Reconstructions sections"

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT02883140 - Imaging Study of 3D-CBCT Sialography and MRI Sialography in Non Tumor Salivary Diseases | Biotech Hunter | Biotech Hunter